News archive

Feb 24, 2016

The HiSeq 4000 build upon the existing HiSeq 2500 platform using the new HiSeq X patterned flow cell technology, providing unparalleled speed and performance. The dual-flow cell HiSeq 4000 System delivers the highest throughput and lowest price per sample across multiple applications. The new sequencer will provide users will faster turnaround time (run time is 3 days compared to 6-11 days in HiSeq 2500) and higher quality, more data per run and longer reads (150 bp paired-end).

Feb 15, 2016

The Oslo University Hospital Genomics and Bioinformatics Core Facilities will relocate to the new Oslo Cancer Cluster Innovation park to colocalise with the section for Molecular Pathology. The colocalisation will facilitate the technology and competence transfer from our genomics environment to accelerate the implementation of high-throughput sequencing for clinical stratification of cancer patients.

Nov 10, 2015
The National Consortium for Sequencing and Personalized Medicine (NCS-PM) has the pleasure of invinting to a Genome Sequencing and Personalized Medicine seminar. The seminar will mark the establishment of the NCS-PM which is a new national research infrastructure funded by the Research Council of Norway to provide researchers in Norway core facility services in human genome sequencing and to facilitate the introduction of personalized, genomic medicine into mainstream healthcare.  
 
We have the pleasure of having Dr. Mark Caulfield Chief Scientist of Genomics England and Dr. Joakim Lundeberg Director of the Genomics platform at the Science for Life Laboratory in Sweden as aspeaker.
 
Place and time: Thursday 26th of November, 1 PM, large auditorium Rikshospitalet.
 
Jun 29, 2015
The National consortium for sequencing and personalized medicine has been granted 60 MNOK for large-scale research infrastructure from the Research Council of Norway. The consortium is a collaboration between the Norwegian Sequencing Center and the Norwegian Genomics Consortium aiming to bring genome sequencing towards personalised medicine. The Genomics Core Facility is one of the leading partner of the consortium participating in cancer sequencing efforts.
Jun 20, 2015

The Genomics Core Facility has been selectect among a small number of European sites for early access to the new Illumina actionable gene panel. Initial testing will be performed in August 2015.

Dec 2, 2014
The article "The regulatory landscape of osteogenic differentiation" publiched by Håkelien AM, in Stemce Cells has been awarded one of teh six excellent articles from the first half of 2014. The entire data set for this paper has been produced at the Genomics Core Facility.
Nov 20, 2014
Leonardo A. Meza-Zepeda and Ola Myklebost in collaboration with David M. Thomas’ group in Australia co-author an article recently published in Cancer Cell (journal impact factor 23.89), entitled “The Architecture and Evolution of Cancer Neochromosomes”. This article describes for the first time, at single base resolution, the architecture of cancer-associated neochromosomes in well- and dedifferentiated liposarcomas.
Oct 10, 2014

The ThunderBolts™ Cancer Panel from Raindance is a comprehensive next-generation sequencing (NGS) panel for profiling important cancer mutations. The ThunderBolts Cancer Panel enables researchers to rapidly detect and cost-effectively analyze mutations on precious FFPE (Formalin-Fixed Paraffin- Embedded), and Fluid Biopsy™ samples (circulating tumor DNA or ctDNA). The ThunderBolts Cancer Panel uses single molecule PCR to target 50 known cancer genes including tumor suppressors, mutation hotspots and drug resistance markers.

Jul 14, 2014
The Oslo node of the ELIXIR Norway Bioinformatics Platform (Bioinformatics Core Facility), the Oslo node of the Norwegian Genomics Consortium (Genomics Core Facility) and the Norwegian Sequencing Centre are happy to invite you to an introductory hands-on course on analysis of next-generation sequencing data using bioinformatics tools. This course is partly administered by the Department of Informatics at the University of Oslo, and can thus give credits to PhD and master students (see below).
Jun 20, 2014

Norwegian Genomics Consortium Genomics Newsletter is a bi-annual newsletter that highlights specific projects performed at the NGC facilities, as well as presents some of our services. This is distributed nation-wide with the Journal of the Biochemical Society.

Please download a PDF version of the latests newsletter here.

May 23, 2014
The Oslo Genomics Core Facility has implemented the Genologics Clarity Laboratory Information Management System (LIMS).

Clarity LIMS is a system built specifically for the needs of clinical or research genomics  laboratories to provide end-to-end workflow tracking and integration. The LIMS provides support for regulatory compliance, and role-based interfaces designed to match the needs of individuals in the lab and collaborators/users.

Mar 14, 2014
The Oslo Genomics Core Facility in collboration with Illumina, has organised ahands-on workshop for pathologists at Oslo Univeristy Hospital.

The TruSight Tumor sequencing panel provides amplicon-based library preparation assay targeting 26 genes frequently mutated in solid tumours. The workshop provided theoretical and hands-on work with the TruSight Tumor protocol, from sample quality control, librrayt preparation, starting a run on the MiSeq instrument and analysing the datareagents, DNA QC, sample indices and oligos targeting identified regions of interest. The TruSight Tumor has been implemented for FFPE material.

Mar 10, 2014
The Oslo Genomics Core Facility has contracted the Genologics Clarity Laboratory Information Management System (LIMS).
Mar 6, 2014
A Raindrop digital PCR system from Raindance has been intalled at the Genomics Core Facility.
Feb 26, 2014
Oslo Genomics Core Facility, Norwegian Sequencing Centre and Illumina arranges Sequencing Seminar, 11 March 2014
Mar 18, 2013

We have started the sequencing of the first samples for the National Personalized Cancer Medicine project lead by the Norwegian Cancer Genomics Consortium. Approximately 200 samples from human melanoma patients will be exome sequenced using Agilent SureSelect Human All Exome V5 target enrichment technology.

Mar 8, 2013

A new Agilent Bravo liquid handling robot has been installed. In collaboration with Agilent technologies, this robotic system will be part of our sequencing pipeline for exome capture at the Norwegian Cancer Genomics Consortium. The Consortium will sequence thousands of cancer samples within the following years, evaluating and implementing genome-based precision medicine for cancer patients.

Feb 18, 2013

The first Hiseq2500 Rapid mode run was successfully completed. Nine RNA-Seq paired-end 2x100bp run was ran in just over 1 day. High cluster density with high quality data generated.  

Feb 4, 2013

Our HiSeq2000 has been upgraded to Hiseq 2500, being the first such instrument in operations in Norway. The upgrade allows to running the Hiseq in Rapid and High output mode. A Rapid run can sequence ChIP-Seq in 7 hours, as well as paired-end RNA-Seq and Exome sequencing in 27 hours. The High output generated larger amount of data in 2 to 11 days.

Jan 30, 2013

Head of the Genomics Core Facility Leonardo Meza-Zepeda will at the NBS Contact meeting present two large projects on Personalized Cancer Medicine that the Core Facility is part of.

Jan 21, 2013
The Genomic Core Facility will be one of 39 exhibitors at the NBS Contact Meeting 2013 in Lillehammer 31 January - 2 February.
Jan 3, 2013

Our Illumina HiSeeq 2000 high-throughput sequencing system is scheduled to be upgraded to HiSeq 2500 in January 2013.

Nov 15, 2012
The Genomics Core Facility were proud sponsors of speakers at the Oslo epigenetics Symposium 8-9 November 2012.
Nov 5, 2012
Hands on course in high-throughput sequencing analysis arranged by the Genomics Core Facility in collaboration with University of Oslo, Norwegian Sequencing center and the Bioinformatics Core Facility.
Oct 20, 2012
In October we had a visit from Beijing Genomics Institute (BGI).
Sep 30, 2012
21-22 September 2012 the Genomics Core Facility were part of the Norwegian Cancer Scociety's stand at Forskningstorget (Oslo Science Fair) in downtown Oslo.

 

 
 
 
 
 
 


News

Feb 24, 2016

The HiSeq 4000 build upon the existing HiSeq 2500 platform using the new HiSeq X patterned flow cell technology, providing unparalleled speed and performance. The dual-flow cell HiSeq 4000 System delivers the highest throughput and lowest price per sample across multiple applications. The new sequencer will provide users will faster turnaround time (run time is 3 days compared to 6-11 days in HiSeq 2500) and higher quality, more data per run and longer reads (150 bp paired-end).

Feb 15, 2016

The Oslo University Hospital Genomics and Bioinformatics Core Facilities will relocate to the new Oslo Cancer Cluster Innovation park to colocalise with the section for Molecular Pathology. The colocalisation will facilitate the technology and competence transfer from our genomics environment to accelerate the implementation of high-throughput sequencing for clinical stratification of cancer patients.


Contact Information:

oslo<at>genomics.no 

Visiting address:
Genomics Core Facility (Room 3-F8-04)
Department of Core facilities
Institute for Cancer Research
New OCCI-building 
 
Norwegian Radium Hospital 
Ullernchaussen 66, Lamell 3, 2B 
NO-0379 Oslo, NORWAY

+47 - 9183 2772 Laboratory
+47 - 9183 3425 Office

Head of Core Facility
Leonardo A. Meza-Zepeda, Dr. philos.

................................................................

................................................................